Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical

Philadelphia, PA, USA / Mexico City, Mexico — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bioproducts for complex regeneration, disease reversion, and aging, and RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on translational therapeutic applications of a range of regenerative and rejuvenation healthcare interventions, have announced a collaboration to focus on novel combinatorial approaches in human disease and wellness. SGR-Especializada (http://www.sgr-especializada.com/), regulatory experts in the Latin American healthcare market, assisted in the relationship.

regenerage

“We are very excited about this collaboration with RegenerAge SAPI de CV,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular and biologic to applications of regenerative and rejuvenative medicine will make for novel and transformational opportunities in a range of degenerative disorders.”

As we close in on $7 trillion in total annual health care expenditures around the globe ($1 trillion spent on pharmaceutical products; $200 billion on new R&D), we are simultaneously witnessing a paradoxical rise in the prevalence of all chronic degenerative diseases responsible for human suffering and death.

With the emergence of such trends including: personalization of medicine on an “n-of-1” basis, adaptive clinical design, globalization of health care training, compassionate use legislative initiatives for experimental therapies, wider acceptance of complementary medical technologies, and the growth of international medical travel, patients and clinicians are more than ever before, exploring the ability to access the therapies of tomorrow, today.

recovering patient

The estimate of the current market size for procedural medical travel, defined by medical travelers who travel across international borders for the purpose of receiving medical care, is in the range of US $40–55 billion.

Additionally, major clinical trial gaps currently exist across all therapeutic segments that are responsible for human suffering and death. Cancer is one prime example. As a leading cause of morbidity and mortality worldwide for many decades, today there are approximately 14 million new cases diagnosed each year, with over 8 million cancer related deaths annually. It is estimated that less than 5% of these patients, take the initiative to participate in any available clinical studies.

“We look forward to working closely with Bioquark Inc. on this exciting initiative,” said Dr. Joel Osorio, Chief of Clinical Development RegenerAge SAPI de CV. “The ability to merge cellular and biologic approaches represents the next step in achieving comprehensive regeneration and disease reversion events in a range of chronic diseases responsible for human suffering and death.”

bioquarklogo

About Bioquark, Inc.
Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

About RegenerAge SAPI de CV

RegenerAge SAPI de CV is a novel clinical company focused on translational therapeutic applications, as well as expedited, experimental access for “no option” patients, to a novel range of regenerative and reparative biomedical products and services, with the goal of reducing human degeneration, suffering, and death.

Nice!

IBM scientists have developed a new lab-on-a-chip technology that can, for the first time, separate biological particles at the nanoscale and could help enable physicians to detect diseases such as cancer before symptoms appear.

As reported today in the journal Nature Nanotechnology (“Nanoscale Lateral Displacement Arrays for Separation of Exosomes and Colloids Down to 20nm”), the IBM team’s results show size-based separation of bioparticles down to 20 nanometers (nm) in diameter, a scale that gives access to important particles such as DNA, viruses and exosomes. Once separated, these particles can be analyzed by physicians to potentially reveal signs of disease even before patients experience any physical symptoms and when the outcome from treatment is most positive. Until now, the smallest bioparticle that could be separated by size with on-chip technologies was about 50 times or larger, for example, separation of circulating tumor cells from other biological components.

nanoDLD

Artistic rendering of IBM’s nanoDLD technology. (Image: Ella Maru Studio for IBM Research)

Read more

Imagine you wake up one morning burning to make the great physicist Max Planck’s face out of copper. (Just go with it.) Sure, you could sculpt it, but there’s a better way. Cut a flat copper sheet into a half-oval, and take a triangle out of the center of its straight edge. Divide it into smaller triangles, bend the sheet so that the two sides of the big triangle touch—and violà! A sheet of flat copper triangles has morphed to match every nook and cranny of Planck’s face. No sculpting required.

If that sounds like magic … well, that’s understandable, because we left a few steps out. Computer scientist Keenan Crane from Carnegie Mellon University actually did this with real copper, and you can see a computer model of the final product at the top of this article. Making Planck’s face wasn’t the point, of course: When Crane cut the sheet into carefully-designed triangles, he brought it into a class of materials known as auxetics, whose curious and complex properties have excited researchers for decades. Someday, auxetics could improve highway shock absorbers, form more comfortable and versatile shoes, and line veins that thicken when expanding.

At least, that’s what the grant applications say. “People give a lot of lip service to how it’s gonna change the world, in terms of curing cancer,” says Crane. “But at this stage people are still trying to figure out just basic questions.” Auxetics all started with a 1987 Science paper by engineer and professor Roderic Lakes. He reported a new kind of polymer foam that contradicted common sense. It expanded in one direction when stretched in another, and contracted in one direction when squeezed in another.

Read more

Apple’s new app to help you do deep breathing to improve your mind, intelligence, and over all health.

APPLE is set to launch a new app that aims to make you healthier through just a few minutes a day of deep breathing.

It is based on the growing field of research proving the biological benefits, including genetic changes, of mind-body medicine.

The Breathe app will be released for the Apple Watch later this year and it will prompt people to take a few minutes every day to stop and focus on their breathing, using the heart-rate sensor in the Watch to monitor the reaction.

Read more

To me, maps always conjure up a sense of exploration.

Back in the Age of Discovery, rudimentary maps allowed European explorers to sail into the vast unknown. They began charting new worlds, and in turn, made newer maps that helped future generations better understand the lands and seas that cover our world.

Now, thanks to a new — if slightly different — type of map, we may be approaching a new age of discovery. One that takes us into the uncharted territories of the mysterious three-pound organ that underlies our thoughts, emotions, hopes and dreams: the human brain.

Read more

My new OpEd article for the San Francisco Chronicle on chip implants and transhumanism: http://www.sfchronicle.com/opinion/openforum/article/Chip-enhanced-political-candidates-coming-soon-8694149.php They also did a 2-minute video of my presidential campaign: http://bit.ly/2aERJxc

The implant can do all sorts of things, like unlock my electronic house door, act as my password on my computer, and even send a text message when people with the right phone and app come near me. Keys, credit cards, ID cards, medical records and passwords — these are all things that can be replaced by a tiny chip in the hand. If having technology in your bodies sounds wacky, consider the millions of people around the world who have artificial hips or dentures, or deaf people who use cochlear implants to hear sounds. […] former Vice President Dick Cheney famously asked to have the Wi-Fi on his heart valve turned off, just in case terrorists tried to hack it. A company in Sylmar (Los Angeles County) called Second Sight already has FDA approval for bionic eyes.

Read more

A new Methuselah Foundation podcast with Dr. Haroldo Silva and David Halvorsen from SENS Research about their work with ALT Cancer!

Hi everyone! Check out this new Methuselah Foundation podcast with Dr. Haroldo Silva and David Halvorsen from SENS Research Foundation. Have a listen and find out why finding Cures for ALT Cancer is so important.

www.mfoundation.org/blog/interviews/episode-007-control-alt-delete-cancer/

Read more

New Gene research.

Look closely at the raw materials that make up any group of cells and you’ll notice some “noise,” a term scientists use to describe natural variations in cellular composition.

A little noise is normal. If a cell produces slightly above-average amounts of a particular protein, common processes like reproduction can continue to operate smoothly. But when things get too noisy, our cells’ machinery starts to misfire. These malfunctioning cells frequently produce mutant offspring that may die off immediately or contribute to the long-term growth of certain forms of cancer.

Now, a team of Virginia Tech researchers is leading an effort to learn more about the mysterious genetic factors responsible for regulating cellular noise levels, backed by a $500,000 grant from the National Science Foundation.

Read more